Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant IMRT + Raltitrexed for Gastric Cancer
NCT03392103Phase 2Unknown
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed in gastric cancer (GC), sponsored by Zhongnan Hospital of Wuhan University. Status: unknown.
02
Drugs
raltitrexed
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03392103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392103.